#1David Yang
Partner
Lux Capital
David backs scientific founders in therapeutics, R&D tooling, and biopharma infrastructure, looking for research edges early enough to matter. His research and company-building background supports a t
Firm-level: Lux says it can invest from an initial $100K through high-conviction follow-ons as large as $100M across the company-building arc. This is not David's personal standard check range.